AAV-GFP-iCre (AAV1) AAV

Name 
AAV1-GFP-iCre
Cat No 
7084
Availability
Immediate

Cre recombinase is used as a tool to genetically modify genes, such as to delete a segment of DNA flanked by LoxP sites in cells or experimental animals.

By applying the mammalian codon usage to Cre recombinase, expression of Cre is improved in the mammalian cells. This improved Cre (iCre) gene also reduce the high CpG content of the prokaryotic coding sequence, thereby reducing the chances of epigenetic silencing in mammals.

This AAV1 stock expresses an improved Cre (iCre) along with eGFP under a control of the same CMV promoter. The Cre and eGFP was separated by a 2A peptides.

7084
AAV1-GFP-iCre

Ready-to-use AAV-GFP-iCre (AAV1). AAV1-GFP-Cre AAV1-GFP-iCre 7084

$495.00
Request Volume Pricing or Customization

Product Details

AAV Serotype
AAV1
AAV ITR
AAV2
Promoter
CMV (ubiquitous)
Reporter
eGFP
Storage Buffer
PBS/5% Glycerol
Titer
1x10^13 GC/ml
Viral Backbone
Recombinant AAV
Volume (µL)
20

Recently Viewed Products

Ad-m-B4GALT6

Cat No: ADV-253569

About Storage Conditions

All our viral products should be kept at -80°C. At this temperature, the virus will remain stable for 6-12 months (and in some cases, up to 2 years). Once thawed, the product can be stored at 4°C for 2-3 weeks without significant loss of biological activity. We recommend aliquoting your vectors into low protein binding tubes upon receipt. This helps avoid repeated freeze-thaw cycles, as well as prevent loss of virus. To maintain accurate titer, aliquot in at least 20ul per tube.